Detalles de la búsqueda
1.
Has the Incidence of Inflammatory Bowel Disease Peaked? Evidence From the Population-Based NorDIBD Cohort 1978-2020.
Am J Gastroenterol;
118(3): 501-510, 2023 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36728238
2.
Vedolizumab as first-line biological therapy in elderly patients and those with contraindications for anti-TNF therapy: a real-world, nationwide cohort of patients with inflammatory bowel diseases.
Scand J Gastroenterol;
56(9): 1040-1048, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34224299
3.
Increased risk of obstructive lung disease in inflammatory bowel disease: A population-based cohort study.
United European Gastroenterol J;
12(4): 477-486, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38183388
Resultados
1 -
3
de 3
1
Próxima >
>>